# ğŸ’¹ Forecasting India's Pharma Opportunity Using OECD Health Data

This project analyzes global pharmaceutical spending patterns using **OECD healthcare data** (1970â€“2016) to **forecast India's future market trajectory**. We apply these insights to simulate revenue potential, breakeven points, and strategic opportunities for healthcare startups like **Karkinos**, operating in the Indian oncology space.

---

## ğŸŒ What is OECD Data?

The **Organisation for Economic Co-operation and Development (OECD)** collects standardized healthcare spending metrics across 30+ developed countries.

This project leverages:
- **Pharmaceutical spending per capita** (in USD PPP)
- Historical data across 40+ years
- Countries including USA, Germany, Turkey, Mexico, Japan, and the OECD average

By comparing India's estimated current spending (~$90) to countries like Turkey (~$195) and the OECD average (~$580), we simulate a **realistic, data-driven path for India's growth**.

---

## ğŸ¯ Project Objective

To use OECD health data to:
- Benchmark India's pharma expenditure trajectory
- Forecast per capita spending through 2030
- Simulate total market size and revenue opportunity
- Model ROI, breakeven, and profitability for a hypothetical player like Karkinos

---

## ğŸ“Š Dataset Overview

- **Source:** [OECD Health Statistics](https://data.oecd.org/)
- **Metric Used:** `Pharmaceutical sales (USD PPP per capita)`
- **Time Span:** 1970â€“2016
- **Scope:** 30+ countries, annual values
- **File:** `OECD_pharma_spending.csv`

---

## ğŸ“ˆ Key Features & Insights

| Feature | Description |
|---------|-------------|
| ğŸ“Š **CAGR Modeling** | Uses historical growth from Turkey and Mexico to forecast India's trend |
| ğŸ’¡ **Benchmarking** | Indiaâ€™s current per capita pharma spend is far below global norms |
| ğŸ§® **Market Sizing** | Forecasts Indiaâ€™s total pharma market to reach $220B+ by 2030 |
| ğŸ’¸ **Scenario Modeling** | Simulates revenue from 0.25%, 0.5%, and 1% market capture |
| ğŸ§¾ **Financial Model** | Includes CapEx, OpEx, ROI, and breakeven year |
| ğŸ“‰ **Inequality Gap** | Visualizes disparities in access and affordability between countries |

---

## ğŸ“ Project Structure

```bash
karkinos-oecd-pharma-analysis/
â”œâ”€â”€ data/
â”‚   â””â”€â”€ OECD_pharma_spending.csv
â”œâ”€â”€ notebooks/
â”‚   â””â”€â”€ oecd_india_forecast_model.ipynb
â”œâ”€â”€ dashboards/
â”‚   â””â”€â”€ financial_forecast_model.xlsx
â”œâ”€â”€ reports/
â”‚   â””â”€â”€ market_forecast_summary.pdf
â”œâ”€â”€ README.md
â””â”€â”€ requirements.txt
